Table 2. Expression of ER and PR in primary and metastatic PTC cases.
| Primary | Metastatic | Test | p value | ||
|---|---|---|---|---|---|
| ER | Negative | 50 (80.7%) | 2 (33.3%) | FE = 6.8 | 0.02 S |
| Positive | 12(19.3%) | 4(66.7%) | |||
| PR | Negative | 38(61.3%) | 6(100%) | FE = 3.6 | 0.08 |
| Positive | 24(38.7%) | 0(0%) | |||
| Primary | Metastatic | Test | p value | ||
|---|---|---|---|---|---|
| ER | Negative | 50 (80.7%) | 2 (33.3%) | FE = 6.8 | 0.02 S |
| Positive | 12(19.3%) | 4(66.7%) | |||
| PR | Negative | 38(61.3%) | 6(100%) | FE = 3.6 | 0.08 |
| Positive | 24(38.7%) | 0(0%) | |||